The Office of the United States Trade Representative (USTR) announced the further extension of the 352 reinstated exclusions and 77 COVID-related exclusions in the China Section 301 Investigation until December 31, 2023. The extension will allow for further consideration under the statutory four-year review. For specific questions on customs classification or implementation of the product…
Read More »
The Office of the U.S. Trade Representative (USTR) has announced that it is extending 77 of 81 Section 301 exclusions of COVID-19 related products through September 30. The other four will expire at the end of May. Previously, all the exclusions had been scheduled to end May 15. The products that will not be extended…
Read More »
The U.S. Court of International Trade (CIT) has given its opinion that the Office of the U.S. Trade Representative (USTR) complied with the court's remand instruction. USTR was asked to prove that it had considered the numerous public comments and thousands of exclusion requests—before deciding on the exclusions and the final lists of affected items—while…
Read More »
Before midnight of the commentary deadline, nearly 1,500 comments were received. In review of the comments, the majority of companies—as well as trade groups from agriculture, retailers, and manufacturing—have told the Office of the U.S. Trade Representative (USTR) that the Section 301 tariffs on $350 million in Chinese goods have not achieved their aim. Instead,…
Read More »
UPDATE: 2/7/2023—USTR is extending the 81 medical product exclusions until May 15, according to a Federal Register publication notice. The Office of the U.S. Trade Representative (USTR) is extending exclusions of 81 medical-care products from Section 301 China tariffs until February 28, 2023. USTR felt this determination was warranted to continue combatting the needs from…
Read More »
The Office of U.S. Trade Representative (USTR) is requesting comments regarding the Section 301 duties starting, November 15, 2022. It is strongly recommended that importers complete the questionnaire. Any additional comments may help shape the policy of the USTR and the Biden administration on Section 301 duties. While providing comments to the USTR and/or a…
Read More »
Although the Court of International Trade’s (CIT) findings that the Office of the U.S. Trade Representative (USTR) had authority to impose Lists 3 and 4A tariffs did hit the over 3,600 lawsuits challenging the tariffs hard, not all is lost for the importers. In the long-awaited opinion, the court ruled against the plaintiffs' argument that…
Read More »
The Office of the U.S. Trade Representative (USTR) has decided to extend 137 exclusions covered under List 1, 59 exclusions on List 2, 266 exclusions on List 3, and 87 exclusions on List 4. Except for exclusions related to the COVID-19 pandemic, all of these exclusions have expired. Specifically, the exclusions for most of these…
Read More »
The three judges at the U.S. Court of International Trade, who are presiding over the Section 301 litigation, have scheduled for an oral argument to be held in New York City, on February 1. They also plan to broadcast the proceedings using a dedicated YouTube channel, which has yet to be identified. This news demonstrations…
Read More »
The Office of the U.S. Trade Representative (USTR) has announced an extension of 81 Section 301 tariff exclusions—which include certain medical-care products needed to address the COVID-19 pandemic—until May 31, 2022. USTR has also stated that the notice, “extends the 99 exclusions scheduled to expire on November 14, 2021, through November 30, 2021. Those exclusions…
Read More »
© 2023 Mohawk Global OTI No. 003952NF Terms of Use Privacy Policy